HIV/AIDS vaccines: 2007. (Q36986517)

17 August 2017

1 reference

title

HIV/AIDS vaccines: 2007. (English)

1 reference

17 August 2017

1 reference

Robinson HL

1

1 reference

PubMed ID

17971817

17 August 2017

language of work or name

English

0 references

publication date

31 October 2007

1 reference

Clinical Pharmacology & Therapeutics

17 August 2017

1 reference

17 August 2017

82

1 reference

17 August 2017

6

1 reference

17 August 2017

686-693

1 reference

Approaching the asymptote? Evolution and revolution in immunology

17 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

Vaccine-induced CD8+ central memory T cells in protection from simian AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Complete nucleotide sequence of the AIDS virus, HTLV-III

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Live attenuated HIV vaccines: pitfalls and prospects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

HIV-1: nature's master of disguise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Identifying epitopes of HIV-1 that induce protective antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Mechanism of neutralization of influenza virus infectivity by antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

T cell vaccines for microbial infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Cross-presentation, dendritic cells, tolerance and immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Translating innate immunity into immunological memory: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Central memory and effector memory T cell subsets: function, generation, and maintenance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

An innately interesting decade of research in immunology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Vaccinia virus: a selectable eukaryotic cloning and expression vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

New hope for an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Progress toward an HIV vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Highly attenuated poxvirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Thailand's Prime-Boost HIV Vaccine Phase III.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100408

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100408

1 reference

17 August 2017

1 reference

PubMed ID

17971817